Gregory William Henkel
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$8.3MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $8.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 18, 2022 | NIH | SBIR Phase II Pre-IND Development of an Arenavirus Antiviral | $997K | ARISAN THERAPEUTICS INC |
| Feb 22, 2021 | NIH | SBIR Phase II Pre-IND Development of an Arenavirus Antiviral | $1000K | ARISAN THERAPEUTICS INC |
| Apr 9, 2020 | NIH | SBIR Phase II Development of a Highly Sensitive Quantitative Rapid Digital LSPR Diagnostic for Acute Dengue and Zika Virus Infection | $1.0M | ARISAN THERAPEUTICS INC |
| Mar 2, 2020 | NIH | SBIR Phase II Pre-IND Development of an Arenavirus Antiviral | $1.0M | ARISAN THERAPEUTICS INC |
| Apr 29, 2019 | NIH | SBIR Phase II Development of a Highly Sensitive Quantitative Rapid Digital LSPR Diagnostic for Acute Dengue and Zika Virus Infection | $1.0M | ARISAN THERAPEUTICS INC |
| Mar 2, 2017 | NIH | SBIR Phase II Arenavirus Antiviral Lead Optimization | $1.5M | ARISAN THERAPEUTICS INC |
| Jul 18, 2016 | NIH | STTR Phase I Ultrasensitive Point-of-Care Diagnostics of Viral Biomarkers and Infectious Diseases | $300K | ARISAN THERAPEUTICS INC |
| Mar 28, 2016 | NIH | SBIR Phase II Arenavirus Antiviral Lead Optimization | $1.5M | ARISAN THERAPEUTICS INC |
Peer ranks
Federal funding#103
Awards as PI#190
Patents#273
Companies
- ARISAN THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.